SLC5A2 and diabetic kidney disease: Effective management of diabetic nephropathy necessitates a comprehensive approach that includes stringent glycemic control, meticulous blood pressure regulation, and the use of renin-angiotensin-aldosterone system (RAAS) inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), and sodium-glucose cotransporter-2 (SGLT-2) inhibitors.